These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 2092970

  • 1. Antihypertensive efficacy of urapidil versus hydrochlorothiazide alone in patients with mild to moderate essential hypertension and of their combination in nonresponders to monotherapy.
    Fariello R, Dal Palu C, Pessina A, Semplicini A, Pirrelli A, Vulpis V, Carretta R, Bellini G, Buoninconti R, Wurst W.
    Drugs; 1990; 40 Suppl 4():60-2. PubMed ID: 2092970
    [No Abstract] [Full Text] [Related]

  • 2. Clinical aspects of antihypertensive therapy with urapidil. Comparison with hydrochlorothiazide.
    Distler A, Haerlin R, Hilgenstock G, Passfall J.
    Drugs; 1990; 40 Suppl 4():21-7; discussion 28-30. PubMed ID: 2092965
    [Abstract] [Full Text] [Related]

  • 3. [Antihypertensive effect of urapidil in mild to moderate arterial hypertension. Randomized, double-blind versus placebo study].
    Amodeo C, Barros LM, Batlouni M, Sousa JE.
    Arq Bras Cardiol; 1993 Aug; 61(2):127-30. PubMed ID: 8297222
    [Abstract] [Full Text] [Related]

  • 4. A comparison of initial treatment with losartan/HCTZ versus losartan monotherapy in chinese patients with mild to moderate essential hypertension.
    Li Y, Liu G, Jiang B, Gao R, Chen L, Su L, Li J.
    Int J Clin Pract; 2003 Oct; 57(8):673-7. PubMed ID: 14627176
    [Abstract] [Full Text] [Related]

  • 5. Urapidil. A reappraisal of its use in the management of hypertension.
    Dooley M, Goa KL.
    Drugs; 1998 Nov; 56(5):929-55. PubMed ID: 9829161
    [Abstract] [Full Text] [Related]

  • 6. Antihypertensive effects of urapidil and clonidine: a double-blind cross-over study.
    Kanniainen E, Heikkilä O, Jääskeläinen T, Lilja M, Jounela AJ.
    Eur J Clin Pharmacol; 1985 Nov; 28(1):35-9. PubMed ID: 3886400
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study.
    Barrios V, Boccanelli A, Ewald S, Girerd X, Heagerty A, Krzesinski JM, Lins R, Rodicio J, Stefenelli T, Woittiez A, Böhm M.
    Clin Drug Investig; 2007 Nov; 27(8):545-58. PubMed ID: 17638395
    [Abstract] [Full Text] [Related]

  • 8. Pinacidil with and without hydrochlorothiazide. Dose-response relationships from results of a 4 x 3 factorial design study.
    Goldberg MR, Offen WW.
    Drugs; 1988 Nov; 36 Suppl 7():83-92. PubMed ID: 3076140
    [Abstract] [Full Text] [Related]

  • 9. Urapidil compared with diuretics in the treatment of mild-to-moderate essential hypertensive patients: effects on glucose metabolism, insulin sensitivity, and lipid profile.
    De Lima MD, Kohlmann NE, Neves FA, Zanella MT, Ribeiro AB, Kohlmann O.
    Blood Press Suppl; 1994 Nov; 4():53-6. PubMed ID: 7804514
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative efficacy and safety of lofexidine and clonidine given alone or concomitantly with hydrochlorothiazide in hypertensive outpatients.
    Beitman RE, Kuzma RJ, McMahon FG, Morledge J, Mroczek W, Rolf CN, Tsai TH.
    Arzneimittelforschung; 1982 Nov; 32(8a):988-93. PubMed ID: 6753858
    [No Abstract] [Full Text] [Related]

  • 12. Double-blind comparison of urapidil and prazosin in the treatment of patients with essential hypertension.
    Kaneko Y.
    Drugs; 1988 Nov; 35 Suppl 6():156-63. PubMed ID: 3042355
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of once-daily urapidil treatment in mild or moderate essential hypertension assessed by ambulatory 24-hour blood pressure monitoring.
    Trimarco B, Rosiello G, Feldhaus P, Steinijans VW, Vecchione F, Cuocolo A, Lembo G, Volpe M.
    Drugs; 1988 Nov; 35 Suppl 6():173-81. PubMed ID: 3402355
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 15. Comparison of urapidil and atenolol in hypertension.
    Török E, Wagner M, Podmaniczky M.
    Drugs; 1988 May; 35 Suppl 6():164-72. PubMed ID: 3042356
    [Abstract] [Full Text] [Related]

  • 16. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
    Pool JL, Schmieder RE, Azizi M, Aldigier JC, Januszewicz A, Zidek W, Chiang Y, Satlin A.
    Am J Hypertens; 2007 Jan; 20(1):11-20. PubMed ID: 17198906
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Randomized, double-blinded trial evaluation of valsartan/hydrochlorothiazide combination therapy in mild to moderate essential hypertension in north-east China.
    Zhang S, Yu B, Li L, Du Z, Guan Z.
    J Int Med Res; 2008 Jan; 36(4):630-7. PubMed ID: 18652757
    [Abstract] [Full Text] [Related]

  • 19. Zofenopril plus hydrochlorothiazide: Combination therapy for the treatment of mild to moderate hypertension.
    Zanchetti A, Parati G, Malacco E.
    Drugs; 2006 Jan; 66(8):1107-15. PubMed ID: 16789795
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.